Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYMPHONY ND: Enarodustat vs darbepoetin alfa in non-dialysis CKD anemia
jRCT2080223814Phase 3Completed
- Sponsor
- Japan Tobacco
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of enarodustat in anaemia (2 arms), sponsored by Japan Tobacco. Primary endpoint: Hemoglobin maintenance over 24 weeks. Started Feb 2018; status: completed.
02
Drugs
enarodustat
03
Conditions
anaemia
Beyond the preview
Go deeper on jRCT2080223814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223814.